"The Carl & Dorothy Bennett Cancer Center combines state-of-the-art technology and advanced clinical knowledge with patient-centered care. Learn more here."

During the past decade, Stamford Hospital/Bennett Cancer Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 20 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stamford Hospital/Bennett Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stamford Hospital/Bennett Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Stamford Hospital/Bennett Cancer Center" are "Stage IIA Fallopian Tube Cancer AJCC v6 and v7" (5 trials), "Stage IIB Fallopian Tube Cancer AJCC v6 and v7" (5 trials), "Stage IIC Fallopian Tube Cancer AJCC v6 and v7" (5 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (5 trials) and "Stage IV Ovarian Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Stamford Hospital/Bennett Cancer Center" in a lesser frequency.

Most popular intervention types in "Stamford Hospital/Bennett Cancer Center" are "Drug" (47 trials), "Other" (36 trials), "Biological" (29 trials), "Procedure" (16 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (19 trials), "Laboratory Biomarker Analysis" (17 trials), "Bevacizumab" (14 trials), "Paclitaxel" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Stamford Hospital/Bennett Cancer Center" are 43 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Stamford Hospital/Bennett Cancer Center". undefined are not yet recruiting, 13 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Stamford Hospital/Bennett Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Stamford Hospital/Bennett Cancer Center, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".